Skip to main content

Advertisement

Log in

Urinary 1β-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tohma M, Mahara R, Takeshita H, et al. Synthesis of the 1β-hydroxylated bile acids, unusual bile acids in human biological fluids. Chem Pharm Bull 1986;34:2890–2899.

    CAS  PubMed  Google Scholar 

  2. Koopman BJ, Wolthers BG, van der Molen JC, et al. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid. Biochem Biophys Acta 1987;917:238–246.

    CAS  PubMed  Google Scholar 

  3. Batta AK, Arora R, Salen G, et al. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: Effect of ursodeoxycholic acid treatment. J Lipid Res 1989;30:1953–1962.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamakawa, R., Kimura, A., Aoki, K. et al. Urinary 1β-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy. J Gastroenterol 31, 917–918 (1996). https://doi.org/10.1007/BF02358625

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02358625

Key words

Navigation